Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001638599-17-000527

Director bought 518 shares at $13.75 ($7,123)

From the SEC's structured data for this filing

Trades in this filing

SPRINGER TIMOTHY A · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-06-01 Purchase : show line 1 in the form +518 $13.75 $7,123 16,622 D
Open-market purchases · 518 sh · avg $13.75 · $7,123
Loading xslF345X03/doc4_4755.xml…